At ASM Microbe 2026, Bruker Corporation’s (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is ...
The Bundibugyo virus (Orthoebolavirus bundibugyoense) outbreak in DR Congo has already registered over 300 confirmed cases, including more than 40 deaths (as of May 31, 2026).1 Transmission has been ...
The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...
The USAG Ansbach Directorate of Public Works (DPW) conducts Legionella sampling of bathroom showers at Army Family Housing ...
The 2026 epidemic of Ebola virus disease caused by Bundibugyo virus (species Orthoebolavirus bundibugyoense) in DR Congo and Uganda has been declared a public health emergency of international concern ...
Karnataka launches a statewide antimicrobial resistance surveillance program with TIGS to track resistance trends and inform ...
A chronic lack of investment in development of better tests has left clinicians blind and allows deadly viruses to spread ...
CirrusDx, Inc. (CirrusDx), an infectious disease laboratory and diagnostics company, today announced it now offers ...
Diagnostics start-up LotusDx establishes R&D laboratory at ONE BioHub to advance at-home STI testing
LotusDx, a medtech company developing at-home diagnostic tests for sexually transmitted infections (STIs), today announced it ...
Zacks Small Cap Research on MSN
Cosmos Health opens the door to a new growth market
By Brad Sorensen, CFA NASDAQ: COSM READ THE FULL COSM RESEARCH REPORT Cosmos Health (NASDAQ: COSM) continues to execute on its strategy of building a diversified healthcare platform with the ...
A 45-reference UltraGene range, new respiratory panels and high-multiplex prototypes strengthen ABL Diagnostics ...
In the fight against antimicrobial resistance, the greatest danger is often what cannot be seen right away. A patient arrives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results